|
FRK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.354200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12720000003497E-06 |
| Normal-vs-Stage2 |
2.433400E-01 |
| Normal-vs-Stage3 |
2.2248000000058E-06 |
| Normal-vs-Stage4 |
6.35280000049754E-07 |
| Stage1-vs-Stage2 |
4.434200E-02 |
| Stage1-vs-Stage3 |
6.811800E-01 |
| Stage1-vs-Stage4 |
3.005200E-01 |
| Stage2-vs-Stage3 |
3.738200E-02 |
| Stage2-vs-Stage4 |
2.748300E-02 |
| Stage3-vs-Stage4 |
5.416000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93780000046218E-07 |
| Normal-vs-AfricanAmerican |
4.808000E-02 |
| Normal-vs-Asian |
6.379800E-01 |
| Caucasian-vs-AfricanAmerican |
8.044400E-01 |
| Caucasian-vs-Asian |
4.466400E-01 |
| AfricanAmerican-vs-Asian |
5.749200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.964800E-03 |
| Normal-vs-Female |
1.764430E-03 |
| Male-vs-Female |
7.714400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.018460E-04 |
| Normal-vs-Age(41-60Yrs) |
4.595000E-04 |
| Normal-vs-Age(61-80Yrs) |
9.889600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.626000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.285600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.968100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.245900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.300800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.556640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.250200E-01 |
| Classical-VS-Follicular |
5.439800E-03 |
| Classical-VS-Other |
7.062200E-01 |
| Classical-VS-Normal |
2.81719999550845E-08 |
| Tall-VS-Follicular |
2.203600E-02 |
| Tall-VS-Other |
4.017600E-01 |
| Tall-VS-Normal |
4.381200E-03 |
| Follicular-VS-Other |
8.477800E-03 |
| Follicular-VS-Normal |
3.587400E-01 |
| Other-VS-Normal |
1.060240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.738100E-02 |
| Normal-vs-N1 |
7.01439994976738E-09 |
| N0-vs-N1 |
2.530200E-02 |
|
|
